Brain Cancer – Tackling the Intractable: Novel Targets and Approaches


  • Minesh P. Mehta, MD, Medical Director, Maryland Proton Treatment
    Center, University of Maryland


  • Lauren Abrey, MD, Oncology Development Site Head, F. Hoffmann-La Roche Inc.
  • Thomas Davis, MD, CMO and SVP Clinical Development, Celldex Therapeutics
  • H. Ian Robins, MD, PhD, Faculty, University of Wisconsin School of Medicine and Public Health
  • Eric Rowinsky, MD, Chief Medical Officer, Head of Research & Development, Stemline Therapeutics